1. Introduction {#sec1}
===============

*Plasmodium falciparum*, the leading causative species of malaria, is a protozoan parasite transmitted by female *Anopheles* mosquitoes when they bite humans to obtain their blood meal. Globally, malaria transmission remains undeterred with epidemiological data showing that malaria affected about 228 million people with approximately 405,000 deaths in 2018 ([@bib39]). Kenya is one of the malaria-endemic countries in sub-Saharan Africa with highland areas in the North Rift region, such as Nandi, Uasin Gishu, and Baringo Counties, experiencing epidemic malaria ([@bib20]; [@bib27]). Despite great strides made in the use of insecticides, anti-malarial drugs, and effective healthcare services, prevention and control strategies of malaria are still challenging due to the emergence of drug resistance ([@bib3]; [@bib10]; [@bib26]; [@bib33]; [@bib40]). Hence, there is a need to develop new strategies that target the transmission of malaria in both epidemic and endemic regions.

Gametocytogenesis is a critical stage in the human-to-mosquito transmission of *P. falciparum.* In sexual development, about 10% of schizonts undergo gametocytogenesis, leading to the formation of gametocytes ([@bib18]). Transmission occurs when a mosquito bites and ingests gametocytes together with the blood meal. In the mosquito midgut, gametocytes grow into macro- and micro-gametes, which fuse to form a zygote ([@bib7]; [@bib18]). In this view, the mechanism of lifecycle demonstrates that gametocytogenesis plays a critical role in the host-vector transmission of malaria parasites.

Current strategies of malaria control focus on the development of transmission-blocking interventions targeting proteins associated with gametocytes and gametes in humans ([@bib10]; [@bib33]). Vaccine development and drug design target different stages of parasites, which are gametocyte stage, pre-erythrocytic stage, and erythrocytic stage ([@bib3]; [@bib10]; [@bib33]). Therefore, understanding of the transmission of malaria parasites plays a significant role in the eradication of malaria across the world.

The elucidation of the mechanism of gametocytogenesis forms the basis of developing transmission-blocking vaccines and drugs. Recent studies have established that *P. falciparum* gametocyte development 1 (*Pfgdv1*) protein induces gametocyte development through the mechanism of antagonizing the silencing effect of heterochromatin protein 1 ([@bib8]; [@bib14]; [@bib15]; [@bib18]; [@bib32]). *Pfgdv1* gene (PF3D7_0935400) codes for a peri-nuclear protein that acts as an upstream activator of gametocytogenesis. Genetic characterizations of this gene and its respective proteins explain their functions and enhance understanding of transmission-blocking targets and gametocyte development in *P. falciparum* isolates.

To achieve the objective of the study, molecular procedures of genomic isolation, amplification, and sequencing generated valid primary sequence data of *Pfdv1* gene from field isolates of *P. falciparum*. Secondary sequences of *Pfgdv1* retrieved from PlasmoDB (<http://www.plasmodb.org>) provided a pool of global data for comparative analysis. Multiple sequence alignment (MSA) identified the presence of single-nucleotide polymorphisms (SNPs), which cause non-synonymous substitutions and non-conservative changes in amino acids. Tajima\'s D revealed that the SNPs identified are under balancing selection in the population of *P. falciparum,* while Single-Likelihood Ancestor Counting (SLAC) identified a codon site with the most substantial positive selection. Ultimately, thermodynamic analysis of these SNPs demonstrated that *Pfgdv1* gene codes for a relatively conserved protein, and thus a potential target of drug design to block the transmission of malaria parasites.

2. Methods {#sec2}
==========

2.1. Study sites {#sec2.1}
----------------

The collection of malaria blood samples was done in Baringo County Referral Hospital (0.48N, 35.74E) in Baringo County, Uasin Gishu County Hospital (0.51N, 35.27E) in Uasin Gishu County, and Kapsabet County Referral Hospital (0.20N, 35.10E) in Nandi County in the highland areas of North Rift region, Kenya, with altitudes of about 2000m. The laboratory work was carried out at Jomo Kenyatta University of Agriculture and Technology (JKUAT), Biochemistry Laboratory. Sequence data analysis was carried out at the University of Nairobi.

2.2. Ethical consideration {#sec2.2}
--------------------------

The study sought ethical clearance from Institutional Research and Ethics Committee (IREC) of Moi University, College of Health Sciences (MU/CHS) and Moi Teaching & Referral Hospital (MTRH) (Reference no. IREC/2017/41). To comply with ethical requirements, the study informed patients regarding the objective of the study, sought written informed consent, allowed voluntary participation, and ensured confidentiality of information collected.

2.3. Blood sample collection {#sec2.3}
----------------------------

Thirty blood samples were collected from patients who presented in three hospitals: Uasin Gishu County Hospital (n = 10) and Baringo County Referral Hospital (n = 10) during the months of October and November 2017, and Kapsabet County Referral Hospital (n = 10) during January and February 2018. The study included malaria patients aged between 20 and 45 years but excluded pregnant women, people with mental illnesses, and prisoners.

Rapid diagnostic kits, Paracheck-Pf® (Orchid Biomedical Systems, Goa, India) were used to detect the presence of malaria parasites ([@bib30]). Thin and thick Giemsa-stained blood films were used to confirm a positive diagnosis of malaria and estimate parasitaemia, respectively ([@bib1]). Approximately 2--3 ml of blood was collected from each patient through venipuncture, stored in EDTA vacutainers (Becton Dickinson, Franklin Lakes, NJ), preserved at -4 °C during transport, and stored at -20 °C awaiting DNA extraction. Details of malaria blood samples recorded were age, date, blood volume, parasitaemia, and sample numbers.

2.4. Isolation and amplification of *Plasmodium* DNA {#sec2.4}
----------------------------------------------------

Genomic DNA was extracted from 30 whole blood samples using QIAamp DNA Mini Kit® (Qiagen, Hilden, Germany) following the manufacturer\'s protocol. The quantity and the quality of the extracted DNA were checked using NanoDrop spectrophotometer (PCRmax Limited, Staffordshire, UK), the nucleic acid ratio (260nm/280nm) ([@bib11]), and 1% agarose gel electrophoresis. The extracted DNA samples were stored at -20 °C to preserve them awaiting amplification.

Primers targeting the *Pfgdv1* gene were designed using Primer3Plus ([@bib37]). The suitability of the designed primers was checked with the Sequence Manipulation Suite ([@bib35]). Parameters considered were primers without hairpin formation, self-annealing, single-base runs, and dinucleotide-base runs, but with substantial GC content, appropriate melting temperatures, and GC clamp. The control primers for the detection of *P. falciparum* DNA targeted a highly conserved 18S rRNA gene as previously described ([@bib24]) (see [Supplementary Table 1](#appsec1){ref-type="sec"}).

The PCR set-up and reactions for the control primer and two sets of primers targeting *Pfgdv1* were done separately in the thermal cycler (Eppendorf Mastercycler Gradient 5331, Perkin-Elmer Corporation, Foster City, CA, USA). The control PCR was amplified using Phusion High-Fidelity PCR Master Mix (Thermo Fisher Scientific, Waltham, MA, USA) in a 20 μl reaction volume. The thermal cycling temperatures were an initial denaturation of 98 °C for 30 s, a denaturation of 98 °C for 10 s, an annealing of 54 °C for 30 s, an extension of 72 °C for 30 s, and a final extension of 72 °C for 10 min.

The first fragment of the gametocyte target gene (*Pfgdv1,* 1306 bp) was amplified with a forward primer (PF400_50F \[5′-GTAGGCGTCGAAATAGTGCT-3'\]) and reverse primer (PF400_1355R \[5′-TCAGGATGTGTTATGGTATC-3'\]) in a 50μl of reaction volume. The PCR conditions were initial denaturation at 98 °C for 30 s, then 35 thermal cycles of denaturation at 98 °C for 10 s, annealing at 54.5 °C for 30 s, and initial extension at 72 °C for 1 min, and eventually a final extension at 72 °C for 10 min. The second fragment of the gametocyte target gene (*Pfgdv1,* 650bp) was amplified with a forward primer (PF400_1081F \[5′-GGTATTCCTGTTGTTATGAG-3'\]) and a reverse primer (PF400_1731R \[5′-AGAAGATGATGAATGCTGACG-3'\]). Similar thermal cycling conditions with the annealing temperature of 57.5 °C for 30 s were used in the amplification of the fragment in 50μl of reaction volume.

The quality and quantity of amplicons were assessed in a 2% agarose gel electrophoresis and purified using QIAquick PCR Purification Kit (Qiagen, Hilden, Germany), according to the manufacturer\'s protocol. The presence and purity of the PCR products purified were checked using 2% agarose gel electrophoresis and packaged in 96-well plate in 30μl volumes. Sequencing by the Sanger method was outsourced at Macrogen (Macrogen Europe, Amsterdam, Netherlands). Sequence data was submitted to GenBank under accession numbers MN986482-MN986511.

2.5. Sequence data analysis {#sec2.5}
---------------------------

The data analysis entailed descriptive analysis of samples, retrieval of secondary sequences, processing of raw sequencing data, and detection of SNPs. Descriptive statistics were used to highlight the distribution of patients based on study sites, gender, age groups, blood volume, and parasitaemia.

Secondary sequences of *Pfgdv1* were retrieved from PlasmoDB [release](plasmodb:release){#intref0015} 46 (<http://PlasmoDB.org>) with 216 *P falciparum* isolates from 20 countries, predominantly Senegal (70), Gambia (65), Mali (23), French Guiana Region (22), Uganda (11), and Brazil (5) ([@bib4]; [@bib28]). The search strategy entailed the selection of SNPs based on gene identification and retrieval of those with over 80% base call, more than 80% read frequency, and greater than 2% minor allele frequency (MAF). Raw sequencing data in the form of chromatograms (ab1 files) were edited, and contiguous sequences were created from reverse and forward sequences, as well as from overlapping sequences, using ChromasPro® (Technelysium Pty Ltd, South Brisbane, Australia). Visual inspection of chromatograms was done to resolve ambiguities in contiguous sequences based on base-call quality scores. Contiguous sequences created were saved in the multifasta format for further bioinformatics analysis.

MSA was done to detect single nucleotide polymorphisms (SNPs). Nucleotide sequences of primary and secondary data were aligned using MUSCLE in MEGA X ([@bib13]; [@bib21]), and then visually inspected to identify SNPs. Furthermore, the aligned sequences were translated into amino acid sequences using the standard genetic code in MEGA X ([@bib21]) and visualized in [@bib17] to differentiate between synonymous and non-synonymous SNPs, along with conservative and non-conservative mutations. The findings of SNPs were tabulated to indicate coding sequence positions, minor alleles frequency, phenotypes, and effects on amino acids. In selection analysis, Tajima\'s D in MEGA X was used to determine if these SNPs are under selection ([@bib36]; [@bib21]), while SLAC (<http://datamonkey.org/slac>) ([@bib29]) was used to calculate the rates of non-synonymous changes (dN) and synonymous changes (dS). Both the primary data (n = 30) and the secondary data (n = 184) were used in selection analysis.

The effect of SNPs on the predicted protein structure was done using STRUM (<https://zhanglab.ccmb.med.umich.edu/STRUM/>), which predicts the stability change of a protein using Gibbs free energy (G). STRUM determines the difference between Gibbs free of folded (Gf) and unfolded (Gu) (ΔG = Gu -- Gf), and then the difference between ΔG of wild type and mutant protein structure (ΔΔG = ΔGm- ΔGw) ([@bib31]). The thermodynamics rationale is that SNPs affect protein stability by reducing free energy difference between the fold and unfold conformations of a protein, and thus, ΔΔG less than zero implies that the mutation destabilizes protein structure.

3. Results {#sec3}
==========

3.1. Characteristic of samples {#sec3.1}
------------------------------

The study analyzed data from 30 samples of blood obtained from malaria patients (Females = 18, Males = 12), 10 samples from Baringo County Referral Hospital (B1-10), 10 samples from Uasin Gishu County Hospital (U1-10), and 10 samples from Kapsabet County Referral Hospital (N1-10). The ages of patients ranged from 21 to 40 years (M = 30.47, SD = 5.11) with the highest proportion of patients (33.3%) in the age group of 31--35 years, followed by 26.7% in age group of 26--30 years and 20% in both age groups of 20--25 years and 36--40 years ([Table 1](#tbl1){ref-type="table"}). Blood volumes withdrawn from patients fluctuated from 1.5 ml to 4 ml (M = 2.35, SD = 0.59) and parasitaemia varied from 5040 to 80,000 parasites/μl (M = 29,060.67, SD = 22,920.31) ([Table 1](#tbl1){ref-type="table"}). Differences in the levels of parasitaemia were statistically insignificant by gender, age groups, and study sites (p \> 0.05).Table 1Characteristics of malaria patients and samples collected.Table 1StatisticsAgeBlood volume drawn (ml)Parasitaemia (p/μl)Mean30.472.3529060.67Standard Deviation5.110.5922920.31Range19.002.5074960.00Minimum21.001.505040.00Maximum40.004.0080000.00Count (N)30.0030.0030.00**GroupsFrequencyPercent (%)M±SD (p/μl)Significance**Females186026434 ± 19020.28F (1,28) = 0.582, p = 0.452Males124033000 ± 27317.0420--25 Years62037846 ± 26433.69F (3,26) = 1.339, p = 0.28326--30 Years826.720542 ± 9792.8931--35 Years1033.323960 ± 19465.4236--40 Years62040133 ± 33527.06Baringo County1033.339164 ± 21733.83F (2,27) = 1.712, p = 0.200Uasin Gishu County1033.320984 ± 19020.28Nandi County1033.327034 ± 25848.98

Age group comparisons of parasitaemia exhibited positive skew in the distribution with the most variation occurring among patients in the group of 36--40 years followed by those in 20--25 years. In contrast, patients in the age group of 26--30 years had the lowest variation in the distribution of parasitaemia, while those in the age group of 32--35 years had a moderate variation with an outlier ([Figure 1](#fig1){ref-type="fig"}). Comparisons of parasitaemia based on gender and study sites depicted disparities in distributions ([Figure 1](#fig1){ref-type="fig"}). In samples from Baringo County, the distribution of parasitaemia exhibited positive skew with a similar range of variation in both gender, but males had a higher median than females. A considerable difference exists in the distribution of parasitaemia in samples from Uasin Gishu because females had a higher median and variation than males. Contrastingly, in samples from Nandi County, males had a lower median and variation than females. Overall, the distributions of parasitaemia displayed positive skew with the highest median in Baringo followed by Nandi County and Uasin Gishu.Figure 1The distribution of parasitaemia levels of 30 patients according to age groups, gender, and study sites.Figure 1

3.2. Quantification of genomic DNA {#sec3.2}
----------------------------------

The concentration of genomic DNA ranged from 8.206 ng/μl to 61.73 ng/μl (M = 30.256, SD = 13.084), while the analysis of the purity of DNA (260 nm/280 nm) indicated that the ratio ranged from 1.714 to 2.176 (M = 1.957, SD = 0.132). The resolution of genomic DNA extracted from the 30 samples obtained from Baringo, Uasin Gishu, and Nandi Counties revealed a band size of approximately 10 kbp (see [Supplementary Figure 1](#appsec1){ref-type="sec"}). The amplification of the target regions of *Pfgdv1* and resolution of PCR products indicated the expected fragment sizes of 1306 bp (see [Supplementary Figure 2](#appsec1){ref-type="sec"}) and 650 bp (see [Supplementary Figure 3](#appsec1){ref-type="sec"}) for the coding regions of 50--1355 and 1081--1731 (see [Supplementary Table 1](#appsec1){ref-type="sec"}).

3.3. Identified single nucleotide polymorphisms {#sec3.3}
-----------------------------------------------

Multiple Sequence Alignment (MSA) of secondary sequences for *Pfgdv1* established the existence of five SNPs ([Table 2](#tbl2){ref-type="table"}). Additionally, MSA of primary sequences of *Pfgdv1* corroborated the existence of these five SNPs, namely, c.650C \> A, c.1193G \> A, c.1249C \> A, c.1491T \> A, and c.1542A \> T ([Table 3](#tbl3){ref-type="table"}). These SNPs give rise to four non-synonymous mutations (c.650C \> A, c.1193G \> A, c.1249C \> A, and c.1491T \> A) ([Figure 2](#fig2){ref-type="fig"}) and one synonymous substitution (c.A1542T). The allelic distribution indicates that mutations of c.650C \> A, c.1249C \> A, and c.1542A \> T form major alleles, whereas those of c.1193G \> A and c.1491T \> A constitute minor alleles. MSA shows that p.P217H and p.H417N dominated all isolates of *P. falciparum,* while p.R398Q and p.D497E were unique to those isolates obtained from Baringo and Uasin Gishu Counties, correspondingly ([Figure 2](#fig2){ref-type="fig"}).Table 2SNPs identified in *Pfgdv1* among secondary sequences from PlasmoDB.Table 2SNPsAllelesAmino Acid ChangePhenotypes% CallsIsolate CountReference (3D7)Minor Allele Frequency (MAF)Genetic CodeAmino Acidc.650C \> ACC (39%)p.P217Hnon- synonymousnon-conservative87.6207c.1193G \> AGA (25%)p.R398Qnon- synonymousnon- conservative83.9205c.1249C \> ACC (18%)p.H417Nnon- synonymousnon-conservative83.5202c.1491T \> ATA (10%)p.D497Enon- synonymousconservative89208c.1542A \> TAA (26%)p.S514SSynonymousconservative90.4200Table 3SNPs identified in *Pfgdv1* among primary sequences from Kenyan Isolates.Table 3SNPsAllelesAmino Acid ChangePhenotypes% CallsIsolate CountReference (3D7)Minor Allele Frequency (MAF)Genetic CodeAmino Acidc.650C \> ACC (37%)p.P217Hnon-synonymousnon-conservative9430c.1193G \> AGA (13%)p.R398Qnon-synonymousnon-conservative9430c.1249C \> ACC (10%)p.H417Nnon-synonymousnon-conservative9430c.1491T \> ATA (10%)p.D497Enon-synonymousconservative9430c.1542A \> TAA (20%)p.S514SSynonymousconservative9430Figure 2MSA outcome visualized using Jalview to highlight four nsSNPs (p.P217H, p.R398Q, p.H417N, and p.D497E) in *Pfgdv1* sequences generated from 30 primary isolates of *P. falciparum* (B1--B10, U1--U10, N1--N10) aligned to the reference sequence (PF3D7).Figure 2

3.4. Selection analysis {#sec3.4}
-----------------------

The analysis of the four-polymorphic sites of nsSNPs indicated that *Pfgdv1* has significant selection (p = 0.007), leading to the rejection of the hypothesis of neutrality ([Table 4](#tbl4){ref-type="table"}). Results for the primary data (n = 30) showed a positive Tajima\'s D (0.209) since observed variation (π = 0.0019) is more than expected variation (Θ = 0.0018), which is statistically significant (p = 0.007). Additionally, results obtained from the secondary data (n = 184) revealed a similar trend due to a positive Tajima\'s D (0.929) with observed variation (π = 0.0018) that is greater than expected variation (Θ = 0.0012). SLAC shows that p.P217H is under the strongest positive selection in both the primary (dN/dS = 361.68) and secondary data (dN/dS = 158.98) based on statistically significant model of nucleotide substitution (The General Time Reversible) and stringent significance level (p \< 0.05) (Tables [5](#tbl5){ref-type="table"} and [6](#tbl6){ref-type="table"}). Moreover, SLAC indicates that p.R398Q and p.D497E are other nsSNPs that exhibit positive selection but not statistically significant (p \> 0.3).Table 4Results from Tajima\'s neutrality test.Table 4MSp~s~ΘπD3040.0070.00180.00190.20918440.0070.00120.00180.929[^1]Table 5Selection analysis outcomes of primary data.Table 5Local Isolates (n = 30)PartitionSitesBranchesBranch LengthSelected at p ≤ 0.05TestedTotalTested% of totalTotalPositiveNegative156115150.0023350.0%0.0046610**Model fitsModelAICClog LParametersRate distributions**Nucleotide GTR4373.58-2163.7523Global MG94xREV4202.49-2071.0630non-synonymous/synonymous rate ratio for ∗test∗100% @ 0.946**DN/DS AnalysisCodon SiteESENSNdSdNdN-dS**2170.632.380.004.000.001.68361.683981.651.350.001.000.000.74158.984970.022.980.001.000.000.3472.174170.003.000.001.000.000.330.005141.001.691.000.001.000.00-214.70Table 6Selection analysis outcomes of secondary data.Table 6Global Isolates (n = 184)PartitionSitesBranchesBranch LengthSelected at p ≤ 0.05TestedTotalTested% of totalTotalPositiveNegative159949490.0033335.30%0.0094511**Model fitsModelAICClog LParametersRate distributions**Nucleotide GTR4890.08-2387.9757Global MG94xREV4706-2288.7364non-synonymous/synonymous rate ratio for ∗test∗100% @ 0.328**Codon SiteESENSNdSdNdN-dS**2170.622.380.004.000.001.68177.704970.022.980.002.000.000.6770.943980.872.130.001.000.000.4749.724170.003.000.005.000.001.670.005141.001.625.000.005.000.00-529.25

3.5. Effect of non-synonymous substitutions {#sec3.5}
-------------------------------------------

The prediction of protein stability changes revealed that three out of four nsSNPs influence the stability of the *Pfgdv1* protein structure ([Table 7](#tbl7){ref-type="table"}). While p.P217H (ddG = -2.22) has a destabilizing effect, p. D497E (ddG = 1.62) and p. H417N (ddG = 0.92) have a stabilizing effect on the protein structure. Since its Gibbs free-energy gap is close to zero, p. R398Q (ddG = 0.07) has no considerable effect on the stability of protein structure.Table 7Gibbs free-energy gaps (ddG) of nsSNPs in *Pfgdv1*.Table 7Amino Acid PositionWild TypeMutant TypeddG217PH-2.22398RQ0.07417HN0.92497DE1.62

4. Discussion {#sec4}
=============

4.1. Parasitaemia range in the study sites {#sec4.1}
------------------------------------------

This study collected blood samples with high levels of parasitaemia as determined by microscopy using the assumed white blood cell (WBC) count of 8000/ul ([@bib1]). Comparative analysis revealed that parasitaemia levels did not vary statistically significantly based on gender, age group, and study sites. However, descriptive statistics indicated that males, patients aged 36--40 years, and study sites of Baringo County and Nandi County exhibited high levels of parasitaemia. In a comparative study, researchers established children aged 5--14 years and in lowland areas had higher levels of parasitaemia than those in highland areas but similar variations by gender ([@bib22]). The extent of malaria transmission explains differences in the level of parasitaemia in various regions.

4.2. Gametocyte development 1 gene {#sec4.2}
----------------------------------

Gametocyte development 1 (*Pfgdv1*) plays a major role in the epigenetic regulation of gametocytogenesis in *P. falciparum.* Genetic characterization indicates that *Pfgdv1* (PF3D7_0935400) is a 1.8kbp gene located in the right arm of chromosome 9 in the sub-telomeric region ([@bib8]). As one of the 5,777 genes of *P. falciparum, Pfgdv1* is an AT-rich gene with a GC content of 14.4%, which is lower than 19.4% of the overall genome of 3D7 strain ([@bib16]; [@bib23]; [@bib28]). The two set of primers designed (PF_0935400_50F \[5′-GTAGGCGTCGAAATAGTGCT-3'\]/PF_0935400_1355R \[5′-TCAGGATGTGTTATGGTATC-3'\], and PF_0935400_1081F \[5′-GGTATTCCTGTTGTTATGAG-3'\]/PF_0935400_1731R \[5′-AGAAGATGATGAATGCTGACG-3'\]) targeted overlapping sections of *Pfgdv1* gene with amplified fragment sizes of 1306 bp and 650 bp, respectively, in 30 isolates obtained from the North Rift region of Kenya, namely, Nandi, Uasin Gishu, and Baringo Counties.

4.3. Single-nucleotide polymorphism analysis {#sec4.3}
--------------------------------------------

As a variation at the genetic level, SNP analysis provides a basic way of characterizing genes and improving their understanding. Based on both primary and secondary data, MSA established the existence of SNPs in *Pfgdv1,* which exhibited the proportion that is greater than 1% as per the conventional requirement of a SNP ([@bib19]). This threshold eliminates the consideration of random mutations as SNPs because they rarely occur in various genes. Results showed that *Pfgdv1* has five SNPs comprising of four non-synonymous mutations and a synonymous substitution with variation in the proportion of minor alleles from 10% to 39% in secondary sequences and 10%--37% in primary isolates. The presence of SNPs in high proportions supports the earlier findings that *Pfgdv1* is the molecular marker of gametocytogenesis and transmission level that exhibits geographical divergence ([@bib12]; [@bib25]). Overall, the analysis of SNPs indicates that mutations of c.650C \> A, c.1249C \> A, and c.1542A \> T formed major alleles, whereas those of c.1193G \> A and c.1491T \> A constituted minor alleles.

The four non-synonymous substitutions identified in *Pfgdv1* had proportions of more than 10% in both global and local populations. The first SNP is a transversion (c.650C \> A) that forms a major allele of about 62% and causes the occurrence of non-synonymous substitution (p.P217H). In a genome-wide analysis study, this SNP is one of the five SNPs that accumulate within the 15kb region of chromosome 9 with the highest value of the fixation index ([@bib25]). Moreover, this form of mutation causes a non-conservative change in amino acid from polar proline (P) to positively charged histidine (H). In their study of determining the rate of gametocyte conversion, [@bib38] established that this mutation increases the effectiveness of gametocyte differentiation in *P. falciparum.*

A subsequent SNP is a transition (c.1193G \> A) that causes non-synonymous substitution (p.R398Q) in approximately 19% of minor alleles. This form of substitution results in a non-conservative change in amino acid from positively charged arginine (R) to polar glutamine (Q). There is a transversion (c.1249C \> A), leading to the formation of a major allele of around 84% and non-synonymous substitution (p.H417N). Another transverse substitution (c.1491T \> A) forms a minor non-synonymous substitution of 10% (p.D497E). The change in amino acid from aspartate (D) to glutamate (E) is conservative because both amino acids have the same properties due to their negatively charged side chains. Conservative amino acids reduce the genetic diversity of a protein, making it a potential target for vaccine development ([@bib34]).

Moreover, the synonymous substitution reported in *Pfgdv1,* which is a transversion (c.1542A \> T) forming a major allele of approximately 77%, does not affect amino acid change. The degeneracy of the genetic code allows more than one form of codon to code for the same amino acid ([@bib9]). Consequently, synonymous substitutions have no biological significance because their occurrence neither change amino acids nor alter protein functions.

4.4. Implication of selection analysis {#sec4.4}
--------------------------------------

The positive values of Tajima\'s D obtained from both primary and secondary data imply that SNPs on *Pfgdv1* exhibit balancing selection. Tajima\'s D values were not only positive for both primary isolates (0.209) and secondary isolates (0.929) but also statistically significant (p \< 0.05). Since the observed variations were higher than the expected variations, it shows that *Pfgdv1* evolve through the process of balancing selection ([@bib36]). Genes that exhibit balancing selection in their evolution are target candidates for elucidating immune mechanisms and vaccine development. SLAC analysis pointed out that p.P217H is the only SNP under the strongest positive selection in *Pfgdv1*. In the genome-wide analysis, [@bib25] established that p.P217H is under differential selection between Gambian and Guinean isolates with a fixation index of 0.3. These findings suggest that p.P217H SNP may play a major role in this protein.

4.5. Effect of SNPs on stability of protein {#sec4.5}
-------------------------------------------

Out of four nsSNP, three of them have a considerable effect on the stability of the predicted protein structure of *Pfgdv1*. A nsSNP causes energy changes in the fold and unfolded conformations of proteins, which have destabilizing or stabilizing effects on protein structure ([@bib31]). Since Gibbs free-energy gap is close to zero, p.D497E has no considerable effect on the thermal stability of the protein structure. Two nsSNPs, p.R398Q and p.H417N, have a stabilizing effect on the protein structure of *Pfgdv1*. Nevertheless, p.P217H is a nsSNP that destabilizes the protein structure because it has a substantial negative free-energy gap (ddG = -2.22). In addition, the SNP is a non-synonymous mutation that causes a non-conservative change in amino acid from polar proline (P) to positively charged histidine (H). The predicted destabilization of the protein structure supports earlier findings that this mutation increases the induction of sexual differentiation and determines transmission rates ([@bib25]; [@bib38]).

4.6. Mechanism of gametocytogenesis {#sec4.6}
-----------------------------------

Gametocytogenesis is an important process in the transmission of *Plasmodium* parasites from humans to mosquitoes. The commitment to gamete production is under a stringent epigenetic control mechanism that allows conversion of 10% of schizonts into transmissible gametes ([@bib18]). In the elucidation of the mechanism of gametocytogenesis, researchers have established critical findings pointing out *Pfgdv1* as a key inducer of transcription ([@bib15]; [@bib18]). Preliminary studies elucidated that gametocytogenesis is under the epigenetic control of AP2-G by heterochromatin protein 1 (HP1), which is a transcriptional repressor ([@bib5]; [@bib6]). Recent studies exposed that *Pfgdv1* induces gametocytogenesis by removing and lessening the repressive effect of HP1 on AP2-G, the master regulator of transcription in gametocytogenesis ([@bib15]; [@bib32]; [@bib38]). Based on the elucidated mechanism of gametocytogenesis, it is apparent that repression or disruption of *Pfgdv1* would cause a constitutive epigenetic silencing due to the stability of HP1. Therefore, SNP characterization highlighted that *Pfgdv1* a relatively conserved protein, making it a potential target in blocking the transmission of *Plasmodium* parasites.

5. Conclusions {#sec5}
==============

In this study, the genetic characterization of the *Pfgdv1* gene reported five SNPs comprising of four non-synonymous substitutions and a synonymous substitution. The presence of four non-synonymous SNPs implies that the *Pfgdv1* gene exhibits some level of diversity among *Plasmodium* species. Furthermore, three non-synonymous SNPs have non-conservative changes on amino acids, which have marked influence on protein structure and function, and thus, suggesting a possible effect on the process of gametocytogenesis. Tajima\'s D indicated that SNPs identified in *Pfgdv1* exhibit balancing selection in both local and global isolates of *P. falciparum.* Additionally, SLAC analysis indicated that p.P217H is under the strongest positive selection and may account for high transmission rates. Thermodynamic analysis of the changes in Gibbs free energy demonstrated that nsSNPs have both stabilizing and destabilizing effects on *Pfgdv1* protein, indicating a net conservative effect. Thus, these findings could form the basis of *in*-*silico* prediction and experimental determination of protein structure to target *Pfgdv1* in drug design studies.
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[^1]: *Abbreviations*: *m* = number of sequences, *S* = number of polymorphic sites, *p*~s~ = p-value (*S*/*n*), Θ = expected varariation (*p*~s~/a~1~), *π* = observed variation (nucleotide diversity), and *D* = the Tajima test statistic.
